Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells

Blood

Volumn 87, Issue 5, 1996, Pages 1972-1976

  Chen, Bengzeng J ^a   Epstein, Joshua ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE SUBPOPULATION; MALE; MYELOMA; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0030049654     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.5.1972.bloodjournal8751972     Document Type: Article

References (22)

1. Mellstedt H, Hammarstrom S, Holm G: Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol 17:371, 1974
2. Kubagawa H, Vogler LB, Capra JD, Conrad ME, Lawton AR, Cooper MD: Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med 150:792, 1979
3. Bast EJ, Van Camp B, Reynaert P, Wiringa G, Ballieux RE: Idiotypic peripheral blood lymphocytes in monoclonal gammopathy. Clin Exp Immunol 47:677, 1982
4. Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, Oken MM, Van Ness B: Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 80:1818, 1992
5. Bergsagel PL, Smith AM, Szczepek A, Mant MJ, Belch AR, Pilarski LM: In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood 85:436, 1995
6. Bergui L, Schena M, Gaidano G, Riva M, Caligaris-Cappio F: Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J Exp Med 170:613, 1989
7. Caligaris-Cappio F, Bergui L, Gregoretti MG, Gaidano G, Gaboli M, Schena M, Zallone AZ, Marchisio PC: Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 77:2688, 1991
8. Pilarski LM, Jensen GS: Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am 6:297, 1992
9. Jensen GS, Belch AR, Mant MJ, Ruether BA, Yacyshyn BR, Pilarski LM: Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma. Am J Hematol 43:29, 1993
10. Pilarski LM, Masellis-Smith A, Belch AR, Yang B, Savani RC, Turley EA: RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: A mediator in B cell malignancy? Leuk Lymph 14:363, 1994
11. Pilarski LM, Andrews EJ, Serra HM, Ledbetter JA, Ruether BA, Mant MJ: Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Am J Hematol 30:53, 1989
12. Pilarski LM, Belch AR: Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood 83:724, 1994
13. Caligaris-Cappio F, Gregoretti MG, Merico F, Gottardi D, Ghia P, Parvis G, Bergui L: Bone marrow micro environment and the progression of multiple myeloma. Leuk Lymph 8:15, 1992
14. Witzig TE, Dhodapkar MV, Kyle RA, Greipp PR: Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 72:108, 1993
15. Witzig TE, Kyle RA, O'Fallon WM, Greipp PR: Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma. Br J Haematol 87:266, 1994
16. Hata H, Xiao H, Petrucci MT, Woodliff J, Chang R, Epstein J: Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells. Blood 81:3357, 1993
17. Gross-Bellard M, Oudet P, Chambon P: Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem 36:32, 1973
18. Deane M, Norton JD: Detection of immunoglobulin gene rearrangement in B lymphoid malignancies by polymerase chain reaction gene amplification. Br J Haematol 74:251, 1990
19. Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, Van Ness B: Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: A technique for sequential quantitation of residual disease. Blood 78:3021, 1991
20. Jensen GS, Belch AR, Kherani F, Mant MJ, Ruether BA, Pilarski LM: Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients. Scand J Immunol 36:843, 1992
21. Bergsagel PL, Belch AR, Pilarski LM: The blood B cells and bone marrow plasma cells in a patient with multiple myeloma include cells with the same N-ras mutation. Blood 84:524a, 1995 (abstr)
22. Thomas X, Xiao HQ, Chang R, Epstein J: Circulating B lymphocytes in multiple myeloma patients contain an autocrine IL-6 driven pre-myeloma cell population. Curr Top Microbiol Immunol 182:201, 1992